For example, the Clinical Pharmacogenomics Implementation Consortium ... Data must then be presented and approved before the updated testing kit can be released. A challenge of IVDR is the ...

Point-of-care DNA testing is now starting. Risk and probability are more difficult concepts in genotypic versus phenotypic assays. Appropriate evaluation of pharmacogenomic tests is a high ...

Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...

The VA Medical Center in North Las Vegas says they are the first hospital in the region to offer a new kind of testing.

Pharmacogenomics is an emerging discipline ... screening of embryos for inherited disorders and non-invasive prenatal testing and newborn screening. Researchers at the CMG and TCELS are now ...